Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Viral Vector Production Market, by Type
1.4.2 Global Viral Vector Production Market, by Indication
1.4.3 Global Viral Vector Production Market, by Application
1.4.4 Global Viral Vector Production Market, by Geography
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter’s Five Forces Analysis
Chapter 4. Strategies Deployed in Viral Vector Production Market
Chapter 5. Global Viral Vector Production Market, by Type
5.1 Global Adeno-Associated Viral Vectors Market, by Region
5.2 Global Lentiviral Vectors Market, by Region
5.3 Global Adenoviral Vectors Market, by Region
5.4 Global Retroviral Vectors Market, by Region
5.5 Global Others Market, by Region
Chapter 6. Global Viral Vector Production Market, by Indication
6.1 Global Cancer Market, by Region
6.2 Global Genetic Disorders Market, by Region
6.3 Global Infectious Diseases Market, by Region
6.4 Global Others Market, by Region
Chapter 7. Global Viral Vector Production Market, by Application
7.1 Global Gene Therapy Market, by Region
7.2 Global Vaccinology Market, by Region
Chapter 8. Global Viral Vector Production Market, by Region
8.1 North America Viral Vector Production Market
8.1.1 North America Viral Vector Production Market, by Type
8.1.1.1 North America Adeno-Associated Viral Vectors Market, by Country
8.1.1.2 North America Lentiviral Vectors Market, by Country
8.1.1.3 North America Adenoviral Vectors Market, by Country
8.1.1.4 North America Retroviral Vectors Market, by Country
8.1.1.5 North America Others Market, by Country
8.1.2 North America Viral Vector Production Market, by Indication
8.1.2.1 North America Cancer Market, by Country
8.1.2.2 North America Genetic Disorders Market, by Country
8.1.2.3 North America Infectious Diseases Market, by Country
8.1.2.4 North America Others Market, by Country
8.1.3 North America Viral Vector Production Market, by Application
8.1.3.1 North America Gene Therapy Market, by Country
8.1.3.2 North America Vaccinology Market, by Country
8.1.4 North America Viral Vector Production Market, by Country
8.1.4.1 US Viral Vector Production Market
8.1.4.1.1 US Viral Vector Production Market, by Type
8.1.4.1.2 US Viral Vector Production Market, by Indication
8.1.4.1.3 US Viral Vector Production Market, by Application
8.1.4.2 Canada Viral Vector Production Market
8.1.4.2.1 Canada Viral Vector Production Market, by Type
8.1.4.2.2 Canada Viral Vector Production Market, by Indication
8.1.4.2.3 Canada Viral Vector Production Market, by Application
8.1.4.3 Mexico Viral Vector Production Market
8.1.4.3.1 Mexico Viral Vector Production Market, by Type
8.1.4.3.2 Mexico Viral Vector Production Market, by Indication
8.1.4.3.3 Mexico Viral Vector Production Market, by Application
8.1.4.4 Rest of North America Viral Vector Production Market
8.1.4.4.1 Rest of North America Viral Vector Production Market, by Type
8.1.4.4.2 Rest of North America Viral Vector Production Market, by Indication
8.1.4.4.3 Rest of North America Viral Vector Production Market, by Application
8.2 Europe Viral Vector Production Market
8.2.1 Europe Viral Vector Production Market, by Type
8.2.1.1 Europe Adeno-Associated Viral Vectors Market, by Country
8.2.1.2 Europe Lentiviral Vectors Market, by Country
8.2.1.3 Europe Adenoviral Vectors Market, by Country
8.2.1.4 Europe Retroviral Vectors Market, by Country
8.2.1.5 Europe Others Market, by Country
8.2.2 Europe Viral Vector Production Market, by Indication
8.2.2.1 Europe Cancer Market, by Country
8.2.2.2 Europe Genetic Disorders Market, by Country
8.2.2.3 Europe Infectious Diseases Market, by Country
8.2.2.4 Europe Others Market, by Country
8.2.3 Europe Viral Vector Production Market, by Application
8.2.3.1 Europe Gene Therapy Market, by Country
8.2.3.2 Europe Vaccinology Market, by Country
8.2.4 Europe Viral Vector Production Market, by Country
8.2.4.1 Germany Viral Vector Production Market
8.2.4.1.1 Germany Viral Vector Production Market, by Type
8.2.4.1.2 Germany Viral Vector Production Market, by Indication
8.2.4.1.3 Germany Viral Vector Production Market, by Application
8.2.4.2 UK Viral Vector Production Market
8.2.4.2.1 UK Viral Vector Production Market, by Type
8.2.4.2.2 UK Viral Vector Production Market, by Indication
8.2.4.2.3 UK Viral Vector Production Market, by Application
8.2.4.3 France Viral Vector Production Market
8.2.4.3.1 France Viral Vector Production Market, by Type
8.2.4.3.2 France Viral Vector Production Market, by Indication
8.2.4.3.3 France Viral Vector Production Market, by Application
8.2.4.4 Russia Viral Vector Production Market
8.2.4.4.1 Russia Viral Vector Production Market, by Type
8.2.4.4.2 Russia Viral Vector Production Market, by Indication
8.2.4.4.3 Russia Viral Vector Production Market, by Application
8.2.4.5 Spain Viral Vector Production Market
8.2.4.5.1 Spain Viral Vector Production Market, by Type
8.2.4.5.2 Spain Viral Vector Production Market, by Indication
8.2.4.5.3 Spain Viral Vector Production Market, by Application
8.2.4.6 Italy Viral Vector Production Market
8.2.4.6.1 Italy Viral Vector Production Market, by Type
8.2.4.6.2 Italy Viral Vector Production Market, by Indication
8.2.4.6.3 Italy Viral Vector Production Market, by Application
8.2.4.7 Rest of Europe Viral Vector Production Market
8.2.4.7.1 Rest of Europe Viral Vector Production Market, by Type
8.2.4.7.2 Rest of Europe Viral Vector Production Market, by Indication
8.2.4.7.3 Rest of Europe Viral Vector Production Market, by Application
8.3 Asia Pacific Viral Vector Production Market
8.3.1 Asia Pacific Viral Vector Production Market, by Type
8.3.1.1 Asia Pacific Adeno-Associated Viral Vectors Market, by Country
8.3.1.2 Asia Pacific Lentiviral Vectors Market, by Country
8.3.1.3 Asia Pacific Adenoviral Vectors Market, by Country
8.3.1.4 Asia Pacific Retroviral Vectors Market, by Country
8.3.1.5 Asia Pacific Others Market, by Country
8.3.2 Asia Pacific Viral Vector Production Market, by Indication
8.3.2.1 Asia Pacific Cancer Market, by Country
8.3.2.2 Asia Pacific Genetic Disorders Market, by Country
8.3.2.3 Asia Pacific Infectious Diseases Market, by Country
8.3.2.4 Asia Pacific Others Market, by Country
8.3.3 Asia Pacific Viral Vector Production Market, by Application
8.3.3.1 Asia Pacific Gene Therapy Market, by Country
8.3.3.2 Asia Pacific Vaccinology Market, by Country
8.3.4 Asia Pacific Viral Vector Production Market, by Country
8.3.4.1 China Viral Vector Production Market
8.3.4.1.1 China Viral Vector Production Market, by Type
8.3.4.1.2 China Viral Vector Production Market, by Indication
8.3.4.1.3 China Viral Vector Production Market, by Application
8.3.4.2 Japan Viral Vector Production Market
8.3.4.2.1 Japan Viral Vector Production Market, by Type
8.3.4.2.2 Japan Viral Vector Production Market, by Indication
8.3.4.2.3 Japan Viral Vector Production Market, by Application
8.3.4.3 India Viral Vector Production Market
8.3.4.3.1 India Viral Vector Production Market, by Type
8.3.4.3.2 India Viral Vector Production Market, by Indication
8.3.4.3.3 India Viral Vector Production Market, by Application
8.3.4.4 South Korea Viral Vector Production Market
8.3.4.4.1 South Korea Viral Vector Production Market, by Type
8.3.4.4.2 South Korea Viral Vector Production Market, by Indication
8.3.4.4.3 South Korea Viral Vector Production Market, by Application
8.3.4.5 Singapore Viral Vector Production Market
8.3.4.5.1 Singapore Viral Vector Production Market, by Type
8.3.4.5.2 Singapore Viral Vector Production Market, by Indication
8.3.4.5.3 Singapore Viral Vector Production Market, by Application
8.3.4.6 Malaysia Viral Vector Production Market
8.3.4.6.1 Malaysia Viral Vector Production Market, by Type
8.3.4.6.2 Malaysia Viral Vector Production Market, by Indication
8.3.4.6.3 Malaysia Viral Vector Production Market, by Application
8.3.4.7 Rest of Asia Pacific Viral Vector Production Market
8.3.4.7.1 Rest of Asia Pacific Viral Vector Production Market, by Type
8.3.4.7.2 Rest of Asia Pacific Viral Vector Production Market, by Indication
8.3.4.7.3 Rest of Asia Pacific Viral Vector Production Market, by Application
8.4 LAMEA Viral Vector Production Market
8.4.1 LAMEA Viral Vector Production Market, by Type
8.4.1.1 LAMEA Adeno-Associated Viral Vectors Market, by Country
8.4.1.2 LAMEA Lentiviral Vectors Market, by Country
8.4.1.3 LAMEA Adenoviral Vectors Market, by Country
8.4.1.4 LAMEA Retroviral Vectors Market, by Country
8.4.1.5 LAMEA Others Market, by Country
8.4.2 LAMEA Viral Vector Production Market, by Indication
8.4.2.1 LAMEA Cancer Market, by Country
8.4.2.2 LAMEA Genetic Disorders Market, by Country
8.4.2.3 LAMEA Infectious Diseases Market, by Country
8.4.2.4 LAMEA Others Market, by Country
8.4.3 LAMEA Viral Vector Production Market, by Application
8.4.3.1 LAMEA Gene Therapy Market, by Country
8.4.3.2 LAMEA Vaccinology Market, by Country
8.4.4 LAMEA Viral Vector Production Market, by Country
8.4.4.1 Brazil Viral Vector Production Market
8.4.4.1.1 Brazil Viral Vector Production Market, by Type
8.4.4.1.2 Brazil Viral Vector Production Market, by Indication
8.4.4.1.3 Brazil Viral Vector Production Market, by Application
8.4.4.2 Argentina Viral Vector Production Market
8.4.4.2.1 Argentina Viral Vector Production Market, by Type
8.4.4.2.2 Argentina Viral Vector Production Market, by Indication
8.4.4.2.3 Argentina Viral Vector Production Market, by Application
8.4.4.3 UAE Viral Vector Production Market
8.4.4.3.1 UAE Viral Vector Production Market, by Type
8.4.4.3.2 UAE Viral Vector Production Market, by Indication
8.4.4.3.3 UAE Viral Vector Production Market, by Application
8.4.4.4 Saudi Arabia Viral Vector Production Market
8.4.4.4.1 Saudi Arabia Viral Vector Production Market, by Type
8.4.4.4.2 Saudi Arabia Viral Vector Production Market, by Indication
8.4.4.4.3 Saudi Arabia Viral Vector Production Market, by Application
8.4.4.5 South Africa Viral Vector Production Market
8.4.4.5.1 South Africa Viral Vector Production Market, by Type
8.4.4.5.2 South Africa Viral Vector Production Market, by Indication
8.4.4.5.3 South Africa Viral Vector Production Market, by Application
8.4.4.6 Nigeria Viral Vector Production Market
8.4.4.6.1 Nigeria Viral Vector Production Market, by Type
8.4.4.6.2 Nigeria Viral Vector Production Market, by Indication
8.4.4.6.3 Nigeria Viral Vector Production Market, by Application
8.4.4.7 Rest of LAMEA Viral Vector Production Market
8.4.4.7.1 Rest of LAMEA Viral Vector Production Market, by Type
8.4.4.7.2 Rest of LAMEA Viral Vector Production Market, by Indication
8.4.4.7.3 Rest of LAMEA Viral Vector Production Market, by Application
Chapter 9. Company Profiles
9.1 Andelyn Biosciences, Inc.
9.1.1 Company Overview
9.1.2 Recent strategies and developments:
9.1.2.1 Partnerships, Collaborations, and Agreements:
9.1.2.2 Geographical Expansions:
9.2 Charles River Laboratories International, Inc.
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Recent strategies and developments:
9.2.4.1 Product Launches and Product Expansions:
9.2.4.2 Acquisition and Mergers:
9.2.4.3 Geographical Expansions:
9.2.5 SWOT Analysis
9.3 Danaher Corporation
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.3.5 SWOT Analysis
9.4 FinVector Oy (Ferring Ventures S/A)
9.4.1 Company Overview
9.5 Thermo Fisher Scientific, Inc.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expenses
9.5.5 Recent strategies and developments:
9.5.5.1 Acquisition and Mergers:
9.5.5.2 Geographical Expansions:
9.5.6 SWOT Analysis
9.6 Novartis AG
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Research & Development Expense
9.6.5 SWOT Analysis
9.7 Takara Bio Inc. (Takara Holdings Inc.)
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expenses
9.8 Avid Bioservices, Inc.
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Recent strategies and developments:
9.8.3.1 Geographical Expansions:
9.9 Oxford Biomedica plc
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Segmental and Regional Analysis
9.9.4 Research & Development Expenses
9.9.5 Recent strategies and developments:
9.9.5.1 Partnerships, Collaborations, and Agreements:
9.9.5.2 Product Launches and Product Expansions:
9.10. Lonza Group Ltd.
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Segmental and Regional Analysis
9.10.4 Research & Development Expenses
9.10.5 SWOT Analysis
Chapter 10. Winning Imperatives of Viral Vector Production Market
Unique Offerings 